GSE1 Inhibitors

GSE1 Inhibitors encompass a varied group of chemicals, primarily designed to influence the molecular landscapes in which GSE1 operates, rather than targeting the protein directly. Their mechanisms are largely centered around altering RNA splicing or transcriptional regulation, both processes GSE1 is intricately associated with. DNA methyltransferase inhibitors, such as 5-Azacytidine and RG108, play roles in the transcriptional realm. By modulating DNA methylation patterns, they can shape the transcriptional environment and consequently the context in which GSE1 operates.

On the other hand, a significant subset of these inhibitors, like Pladienolide B, Isoginkgetin, Meayamycin B, and Spliceostatin A, directly target the splicing machinery. Given GSE1's involvement in RNA splicing, any alteration to this machinery can create ripple effects, possibly influencing the function and roles of GSE1. These splicing modulators, by binding to and inhibiting core spliceosome components or the splicing factor SF3B, ensure that the RNA splicing landscape is transformed. Within this altered landscape, GSE1's ability to bind and regulate its target RNA molecules can be significantly affected.